Albumin is a potent scavenger of reactive oxygen species (ROS). However, modifications in albumin structure may reduce its antioxidant properties and modulate its immune-regulatory functions. We examined alterations in circulating albumin in severe alcoholic hepatitis (SAH) patients and their contribution to neutrophil activation, intracellular stress, and alteration in associated molecular pathways. Albumin modifications and plasma oxidative stress were assessed in SAH patients (n 5 90), alcoholic cirrhosis patients (n 5 60), and healthy controls (n 5 30) using liquid chromatography/mass spectrometry and spectrophotometry. Activation and intracellular ROS were measured in healthy neutrophils after treatment with purified albumin from the study groups. Gene expression of SAH neutrophils was analyzed and compared to gene expression from healthy neutrophils after stimulation with purified albumin from SAH patient plasma. SAH-albumin showed the highest albumin oxidative state (P < 0.05) and prominent alteration as human nonmercaptalbumin 2 (P < 0.05). Plasma oxidative stress (advanced oxidative protein product) was higher in SAH versus alcoholic cirrhosis patients and healthy controls (P < 0.05). Neutrophil gelatinase-associated lipocalin, myeloperoxidase, and intracellular ROS levels were highest in SAH-albumin-treated neutrophils (P < 0.05). Genes associated with neutrophil activation, ROS production, intracellular antioxidation, and leukocyte migration plus genes for proinflammatory cytokines and various toll-like receptors were overexpressed in SAH neutrophils compared to healthy neutrophils (P < 0.05). Expression of the above-mentioned genes in SAH-albumin-stimulated healthy neutrophils was comparable with SAH patient neutrophils, except for genes associated with apoptosis, endoplasmic reticulum stress, and autophagy (P < 0.05). Conclusions: In patients with SAH, there is a significant increase in albumin oxidation, and albumin acts as a pro-oxidant; this promotes oxidative stress and inflammation in SAH patients through activation of neutrophils. (HEPATOLOGY 2017;65:631-646).
T he burden of alcoholic liver disease (ALD) has significantly increased globally in recent times due to changes in lifestyle and limited treatment options.
(1) Severe alcoholic hepatitis (SAH), a complex presentation of ALD with severe and progressive inflammation, continues to have high short-term mortality. (2) Only 10%-35% of heavy drinkers develop such severe forms of ALD. (3) Overwhelming bacterial
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infections are the leading cause of death in SAH, (4) but the precise mechanisms for this phenomenon are unknown. Ethanol and its metabolic products have well-demonstrated hepatotoxicity. (5, 6) The primary reason behind the development of SAH is prolonged injury to the liver cells by the metabolic products of ethanol. (7) Recent data have demonstrated a complex association between ethanol metabolism, inflammation, and innate immunity in the development and progression of SAH. (8) The immunopathological events of SAH involve the activation of innate as well as adaptive immune mechanisms. (3, 8) Studies have demonstrated that neutrophils act as primary inflammatory agents through production of proinflammatory mediators and release of reactive oxygen species (ROS) and various cytokines. (9) In alcohol-induced liver disease, neutrophils are known to infiltrate the liver and reduce the alcohol-induced hepatocellular damage. (10) Studies have reported that excessive neutrophil accumulation in the liver may also initiate injury and contribute to the progression of ALD. (5) In addition to inflammation and immunological events, systemic oxidative stress plays a major role in the pathogenesis and progression of ALD. (10, 11) The oxidative metabolism of ethanol by the alcohol dehydrogenase/aldehyde dehydrogenase system and by the cytochrome P450 enzyme-driven microsomal ethanol oxidizing system in the liver generates a significant amount of ROS such as superoxide anion, hydrogen peroxide, hydroxyl radical, and hydroxyethyl radical. (11) Accumulation of these ROS leads to development of an oxidative milieu in the body. This systemic stress causes oxidative modifications on various proteins and lipids, which results in alteration of various intrinsic and extrinsic immune pathways leading to disease pathogenesis. (12, 13) An important outcome of this systemic oxidation is oxidized human serum albumin (HSA), which is also the principal component of advanced oxidation protein product (AOPP), (14) a marker of oxidative stress. (15) Oxidation of albumin based on the redox state of Cys-34 residue was characterized into (1) human mercaptalbumin (HMA), the reduced and most abundant form of albumin; (2) human nonmercaptalbumin 1 (HNA1), reversibly oxidized form; and (3) human nonmercaptalbumin 2 (HNA2), irreversibly oxidized form. (16) In advanced liver diseases, significant reductions in HMA with a concomitant rise in HNA1 and HNA2 isoforms have been well documented. (17, 18) In addition several other posttranslational modifications of circulating albumin have been reported in liver cirrhosis (19) and in alcoholic hepatitis patients, (20) although the contribution of such modifications in determining the albumin functionality and associated immune response has not been studied. Mass adduct modifications of circulating albumin may contribute to reduction of its antioxidant property and may elicit an immune response in SAH patients. Recent studies have reported that in vitro hypohalous acid modified albumin and in vivo produced oxidized HSA in hemodialysis patients trigger neutrophil oxidative burst and degranulation. (21, 22) The potential role of modified circulatory albumin for modulating neutrophil function and production of excessive ROS in SAH patients is important to understand the pathogenesis of alcoholic hepatitis. We investigated the modifications in circulating albumin and their role in neutrophil activation, intracellular stress, and associated alterations in molecular pathways in SAH patients. patients were clinically followed up for 3 months or until death, whichever occurred first. These patients were managed according to the standard of care, which included intensive care monitoring, high-calorie diet (35-40 cal/kg/day), broad-spectrum antibiotics, and intravenous albumin if the serum albumin level was <2.5 g/dL. Albumin was often infused to prevent the development of any further complications. None of the patients received corticosteroids before the samples were drawn for analysis. Patients with hepatocellular carcinoma, recent gastrointestinal bleeding (<42 days before enrollment), or liver transplantation within 90 days from enrollment or patients who had gone through previous albumin dialysis or received intravenous albumin were excluded from the study. In addition, patients with stable compensated alcoholic cirrhosis (n 5 60) were enrolled as a disease control group in the study. These patients were abstinent from alcohol for at least 1 month. Cirrhosis was diagnosed based on a combination of histopathological, clinical, biochemical, endoscopic, and radiological criteria. Healthy controls (HCs, n 5 30) had no history or clinical evidence of previous or present illness. Laboratory staff was unaware of the clinical details of the study groups at the time of the experiments. ChildTurcotte-Pugh (CTP); Model for End-Stage Liver Disease (MELD); Sequential Organ Failure Assessment (SOFA); Maddrey's discriminant function (DF); and albumin, bilirubin, international normalized ratio, creatinine (ABIC) scores were calculated to determine the severity of liver disease at initial presentation. The institutional review board approved the study protocol, and informed consent was taken from all patients and healthy individuals enrolled in the study.
CHEMICALS
Mass spectrometry (MS)-grade water, acetonitrile, and formic acid were purchased from Sigma-Aldrich (St. Louis, MO). Purified HSA was purchased from Baxter (Gurgaon, India). All reagents were of analytical grade.
MS ANALYSIS OF CIRCULATORY HSA
To study the albumin modifications in SAH patients, MS analysis of HSA was carried out on an electron spray ionization quadrupole time-of-flight MS (Maxis Impact; Bruker Daltonics, Bremen, Germany) coupled to an Agilent 1100 series high-performance liquid chromatograph. Plasma samples of all study groups were diluted with distilled water at a 1:4,000 ratio, and then 8 lL of this diluted plasma was injected into the highperformance liquid chromatography-electron spray ionization MS system. High-performance liquid chromatography separation was performed on a reverse-phase C8 column (Agilent ZORBAX RRHD 300SB-C8, 2.1 mm id 3 50 mm, 1.8 lm threaded column with a pore size of 300 Å) at a flow rate of 0.2 mL/minute using an H 2 O-acetonitrile (with 0.1% formic acid) solvent system under a gradient of 90% H 2 O to 90% acetonitrile over a period of 25 minutes with acquisition starting at 3 minutes. Under auto-MS conditions, mass spectral analysis was performed. A similar analysis was also performed with 5% Baxter albumin solution.
The obtained compound electron spray ionization MS spectra were analyzed using the software Compass data analysis (Bruker Daltonics). Here, after minimizing the base peak chromatogram from the total ion chromatogram, albumin mass chromatograms were obtained and analyzed. The obtained albumin spectra were then deconvoluted within mass range from 66,000-67,000 Da (as the molecular weight [MW] of various albumin isoforms fall within this range (16) ). Finally, from the intensity of the peaks, the abundance of albumin isoforms was measured and the relative abundance of the various HSA isoforms determined by using the following formula (16, 19, (23) (24) (25) :
% ðTotal HSAÞ 
LIQUID CHROMATOGRAPHY-MS METHOD VALIDATION
To validate the liquid chromatography (LC)-MS method for the albumin isoforms' MW and relative abundance percentage (quantitative analysis), one representative plasma sample from HCs, alcoholic cirrhosis (AC) patients, and SAH patients was diluted with distilled water at a 1:2,000 ratio and analyzed six times on the same day and six times over 3 consecutive days on the same LC-MS system. The intraday and interday variabilities in isoform MW and their relative abundance was calculated as described by Naldi et al. (25) The intraday and interday variabilities were expressed as percentages of relative standard deviation (Supporting Table S1 ). In the HC, AC, and SAH groups the relative standard deviation values of various albumin isoforms' MW both for the intraday and interday variabilities were found to be lower than 0.01% (Supporting Table S1 ). Percentage relative standard deviation values for the relative abundance of the various albumin isoforms in HC, AC, and SAH were found to be lower than 8% for the intraday as well as the interday analyses (Supporting Table S1 ).
DETERMINATION OF AOPPs
To determine the level of systemic oxidative stress in SAH patients, circulatory levels of AOPP were determined. Circulatory levels of AOPP were determined in the plasma using a spectrophotometric method. (15, 26) Briefly, the plasma samples (SAH 90, AC 60, and HC 30) were diluted with phosphate-buffered saline (PBS; pH 7.4) in a 1:5 ratio. Two hundred microliters of this diluted plasma was then placed in a 96-well microtiter plate and mixed with 20 lL of glacial acetic acid. For calibration 200 lL of chloramine-T (0-200 lM) as standard and 200 lL of PBS as blank were applied to the microtiter plate and mixed with 10 lL of 1.16 M potassium iodide, followed by mixing of 20 lL of glacial acetic acid. Absorbance was measured at 340 nm using a microplate reader (Multiskan EX; Thermo Scientific), and the AOPP concentration was calculated in chloramine units (micromoles per liter).
PURIFICATION OF ALBUMIN FROM PLASMA
To determine the pro-oxidant potential of modified albumin present in the circulation of SAH patients, albumin was purified from the study groups and tested on healthy neutrophils for activation and oxidative burst. For this, 10 plasma samples of each of the three study groups were obtained randomly from the total enrolled patients and HCs and subjected to albumin purification by a chromatographic method. (22) The patients (10 SAH, 10 AC) and 10 HCs had clinical characteristics representative of their own entire group (Supporting Table S2 ). Briefly, albumin was purified from 1 mL of plasma by affinity chromatography using capture select human albumin affinity matrix (catalog no. 1912970250; Life Technologies). Purified albumin samples were then passed through 7-kDa Zeba spin desalting columns (catalog no. 89893; Thermo Scientific), followed by speed vac on centrivap centrifugal vacuum concentrators (Labconco). The sodium dodecyl sulfate polyacrylamide gel electrophoresis and native polyacrylamide gel electrophoresis documented at least 95% purity and <7% dimers for the purified HSA samples (data not shown). Additionally, purified HSA from different groups was subjected to a Limulus amoebocyte lysate assay (27) for determination of endotoxin contamination using a toxin sensor chromogenic Limulus amoebocyte lysate endotoxin assay kit (catalog no. L00350; Genscript). Trace levels of endotoxin contamination were documented in our purified HSA samples (HC-albumin endotoxin level 5 0.0679 EU/mL, equivalent to 0.9231 pg/mL; AC-albumin endotoxin level 5 0.0686 EU/ mL, equivalent to 0.9325 pg/mL; SAH-albumin endotoxin level 5 0.0688 EU/mL, equivalent to 0.9326 pg/ mL); in addition, endotoxin levels were not significantly different in comparisons for SAH, AC, and HC (Supporting Fig. S1 ). This HSA was then used for stimulation of neutrophils isolated from healthy individuals. Purified albumin was tested individually (10 biological replicates for each of the study groups) on healthy neutrophils for stimulation experiments (activation assay, respiratory burst measurement, and reverse-transcription polymerase chain reaction [RT-PCR] analysis).
NEUTROPHIL ACTIVATION ASSAYS
Neutrophil activation by purified albumin from plasma of SAH patients was assessed by the Michelis et al. method. (28) Neutrophils were isolated from 20 mL peripheral blood of healthy donors using a density gradient centrifugation method. (29) In density gradient isolation of neutrophils, whole blood was carefully layered onto a double-layered gradient, formed by layering equal volumes of hiSep1077 (HiMedia) over granulosep GSM1119 (HiMedia). The isolated neutrophil population was >98% pure, and cell viability was at least 98% as determined by trypan blue staining. The isolated healthy neutrophils (1 3 10 6 ) were then incubated with 16 mg/mL of purified albumin from the study groups. Incubation was terminated after 2 hours by the addition of 2 volumes of ice-cold buffer (PBS, pH 7.4), and the product was centrifuged at 16,200 g for 20 minutes. The supernatants were then collected. Finally, the levels of neutrophil activation markers neutrophil gelatinase associated lipocalin (NGAL) and myeloperoxidase (MPO) (28) were measured in the supernatants by enzyme-linked immunosorbent assay (USCN kit for NGAL, SEB388Hu; Human MPO PicoKine Kit, EK0850) for assessment of neutrophil activation.
MEASUREMENT OF NEUTROPHIL RESPIRATORY BURST
Production of intracellular ROS in healthy neutrophils by purified albumin from plasma of SAH patients was assessed using a dihydrorhodamine-123 (DHR; Sigma; Chemical Abstracts Service no. 109244-58-8) test, according to Mera et al. (22) Neutrophils were isolated from HCs as described above. Then, suspensions of 1 3 10 6 isolated neutrophils were incubated at 378C with DHR (5 lM) for 15 minutes in serum-free medium. After PBS washing, the cells were treated with 16 mg/mL purified albumin from the study groups or Baxter albumin followed by incubation at room temperature (378C) for 1 hour. Finally, the intracellular ROS in albumin-treated neutrophils was measured in terms of mean fluorescence intensity (MFI) of rhodamine by using a flow cytometer (BD-FACS Calibur).
SEMIQUANTITATIVE RT-PCR ANALYSIS
The neutrophil activation-related pathways were studied in a panel of 52 genes associated with activation, ROS production, intracellular antioxidation, endoplasmic reticulum (ER) stress, autophagy, apoptosis, and leukocyte migration as well as genes for inflammatory cytokines and various toll-like receptors (TLRs; see Results for the list of genes). For this in vivo experiment, the neutrophils were isolated from the SAH (n 5 10), AC (n 5 10), and HC (n 5 10) groups. Patients and HCs used for isolation of neutrophils were the same as those used for albumin purification. Isolated neutrophils were then subjected to RNA isolation, followed by complementary DNA synthesis. In parallel, in an ex vivo experiment, neutrophils were isolated from healthy donors. The isolated neutrophils (10 6 cells) were then stimulated with 16 mg/mL purified albumin from the study groups or Baxter albumin for 2 hours. Then, RNA was isolated from the neutrophils and subjected to complementary DNA synthesis. The complementary DNA obtained in vivo and ex vivo was then subjected to gene expression analysis by RT-PCR.
STIMULATION OF HEALTHY NEUTROPHILS WITH IN VITRO OXIDIZED ALBUMIN
To validate the capacity of oxidized albumin to promote neutrophil responses, HSA was oxidized in vitro by ROS generated through a Fenton reaction (30) and tested on healthy neutrophils (Supporting Information).
STATISTICAL ANALYSIS
Results are given as means with standard deviation unless indicated otherwise. Statistical analyses were performed using GraphPad Prism v6 and SPSS statistics 20.0 (IBM, Armonk, NY), with statistical significance set at P < 0.05. For comparison of variables between groups, the unpaired (two-tail) Student t test, one-way analysis of variance, Mann-Whitney U test, and Kruskal-Wallis test were used as appropriate. Comparison between three groups was performed using analysis of variance or Kruskal-Wallis test followed by post hoc comparison by the Bonferroni method. Comparison between two groups was performed using the unpaired (two-tail) Student t test and MannWhitney U test where applicable. Log transformation was applied to make the data normalized. Spearman's correlation was drawn comparing albumin isoforms and severity assessment scores. Receiver operating characteristic analyses were performed to examine the diagnostic accuracy of the prognostic variables. Univariate and multivariate Cox regression analyses were performed to assess the hazard ratio of prognostic variables. Table 1 . The baseline serum albumin hemoglobin was lower, while total leukocyte count, bilirubin, and international normalized ratio were higher in the SAH group compared to other patients. The majority of SAH patients (96%) had ascites and jaundice, with a median bilirubin of 18.45 (range 5-45.4) mg/dL. The median neutrophil percentage in peripheral leukocytes was 78.9% (range 46%-90%). The CTP, MELD, SOFA, DF, and ABIC scores were higher in SAH patients compared to AC patients ( Table 1 ). The median CTP was 11 (range 9-12), MELD was 25 (range 16-32), MELDNa was 29 (range , SOFA was 7 (range 5-9), DF was 71.5 (range 33-157), and ABIC was 7.5 (range 5.4-9.2) in SAH patients (Table 1) .
Results

PATIENT CHARACTERIZATION
ALTERED ALBUMIN ISOFORM DISTRIBUTION IN SAH
Posttranslational modification of circulating HSA is reported in cirrhosis and alcoholic hepatitis patients. (19, 20) Circulating albumin isoforms in SAH patients' plasma were analyzed using LC-electron spray ionization MS. As reported earlier, we also found the MS spectra of circulating HSA characterized by several multicharged ions, a result of addition of 45-62 protons. (22, 23) (16, 19) (Fig. 1A ; Supporting Table S3 ). Interestingly, deconvolution of the commercially available (5% Baxter) albumin mass spectrum also showed eight peaks ( Fig. 1A ; Supporting Table S3 ). Further quantification of the relative abundance of the above-mentioned albumin isoforms showed that total HMA was significantly (P < 0.05) lower in SAH (40%) versus AC (46%) or HC (64.8%) (Fig. 1B) . Total HNA1 was significantly (P < 0.05) higher in SAH (44.5%) and AC (47.8%) compared to HC (28.6%) (Fig. 1C) . Similarly, irreversibly oxidized albumin (HNA2) was significantly increased in SAH (15.5%) compared to AC (6.2%) or HC (6.6%) (P < 0.05) (Fig. 1D ). In addition, albumin oxidation state (AOS; i.e., ratio of oxidized state to reduced state) was significantly higher in SAH (1.5) compared to AC (1.2) and HC (0.5) (P < 0.05) (Fig. 1E) . On the other hand, HSA-L was significantly lower in the SAH (2.6%) and AC (2.6%) groups compared to HC (3.6%) (P < 0.05). Moreover, nonglycosylated HMA was significantly lower in SAH (17.3%) compared to AC (29.5%) or HC (48.4%) (P < 0.05). Glycosylated HMA was significantly higher in SAH (17.4%) compared to AC (11.5%) and HC (10.6%) (P < 0.05), while HSA1CYS-DA was significantly higher in SAH (3.2%) compared AC (2.8%) and HC (2.8%) (P < 0.05). Interestingly, Cys-HNA1 was significantly higher in AC (34.3%) compared to SAH (26.3%) and HC (21.5%) (P < 0.05). Further, (Cys1Glc)-HNA1 was significantly higher in SAH (15.0%) than AC (10.7%) or HC (4.3) (P < 0.05). The results suggest that in SAH patients circulatory albumin undergoes remarkable posttranslational modifications, leading to a distinct distribution pattern of various albumin isoforms, with the irreversibly oxidized form (HNA2 or HSA1SO 2 H), being the highest (15.5%) ( Table 2) .
CORRELATION OF ALBUMIN ISOFORMS WITH MORTALITY AND SEVERITY IN SAH PATIENTS
Spearman correlation analysis (Supporting Table  S4 ) revealed that HNA2, AOS, Cys-HNA1, and (Cys/Cys1Glc)-HNA1 ratios directly correlated with mortality in SAH patients (r 2 > 0.3, P < 0.05), while (Cys1Glc)-HNA1 was inversely correlated with mortality in SAH patients (Supporting Table S4 ). The area under the receiver operating characteristic curve of HMA, HNA1, HNA2, AOS, HSA-L, Cys-HNA1, (Cys1Glc)-HNA1, (Cys/Cys1Glc)-HNA1, CTP, and SOFA was significantly associated with survivability or mortality (1 month and/or overall) in SAH patients (Supporting Table S5 ). At univariate Cox regression analysis the parameters HMA, HNA2, AOS, HSA-DA, HSA-L, non-Glc-HMA, Cys-HNA1, (Cys1Glc)-HNA1, (non-Glc/Glc)-HMA ratio, (Cys/Cys1Glc)-HNA1 ratio, CTP, MELD, and SOFA were significantly associated with mortality at 1 month and/or overall in SAH patients (Supporting Table S6 ). Further multivariate Cox regression analysis documented significant association of AOS, (Cys1Glc)-HNA1, (Cys/Cys1Glc)-HNA1, CTP, and SOFA with 1 month and AOS, non-Glc-HMA, (Cys/Cys1Glc)-HNA1, and SOFA with overall mortality in SAH patients (Supporting Table S6 ).
INCREASED PLASMA OXIDATIVE STRESS IN SAH
Because oxidation of albumin was high in SAH patients, we assessed the systemic oxidative stress by Fig. 2A) , confirming high levels of oxidative stress in the circulation of SAH patients. 
ALBUMIN FROM SAH PATIENTS ACTIVATES NEUTROPHILS AND INDUCES RESPIRATORY BURST
Measurement of the levels of activation markers in neutrophil supernatants documented significantly higher levels of NGAL and MPO after SAH-albumin treatment (31.4 ng/mL, 53.4 ng/mL) compared to AC-albumin (10.9 ng/mL, 45.4 ng/mL) or HCalbumin (5.1 ng/mL, 26.9 ng/mL) treatment (P < 0.05) (Fig. 2B,C) . Further, the respiratory burst potential of modified albumin from various study groups was tested on healthy neutrophils using the DHR assay. A significant shift in MFI of rhodamine was observed in SAH-albumin-treated healthy neutrophils compared to those treated with AC-albumin, HC-albumin, or Baxter albumin (Supporting Fig. S2 ). On quantitation, a significant (P < 0.05) increase in intracellular ROS was observed in neutrophils incubated with purified albumin from SAH patients in comparison to albumin from other groups (Fig. 2D) ; these results demonstrate that SAH-albumin is capable of activating and degranulating neutrophils as well as inducing oxidative burst in neutrophils better than AC. This may be due to a significant reduction in the native albumin as a result of its enhanced oxidation as observed in SAH compared to AC.
NEUTROPHILS IN SAH PATIENTS ARE ACTIVATED BY CELLULAR STRESS
Neutrophil activation and burst have been linked to the pathogenesis of ALD. (9) Thus, we checked the activation and expression of intracellular stress-related genes in SAH neutrophils. Expression analysis revealed that SAH neutrophils had higher (fold change >1.5) expression of genes associated with neutrophil activation (NGAL), production of ROS (CYBA, NCF2, FMO2, NOX1, NOX4, NOXA1, NOXO1), intracellular antioxidation (CCS, GSR, SOD1, SOD2, SOD3), proapoptosis (CASP1, CASP8, CASP9, BAD, BAX, TNFa), and leukocyte migration (SELE, CEACAM1, ICAM1, ICAM2, PECAM1, VCAM1, OCLN) compared to healthy neutrophils (Fig. 3A) . Further, it was also documented that expression of proinflammatory cytokines (IL1b, IL6, IL7, IL10, IL11, IL15) and various TLR genes (TLR1, TLR2, TLR4, TLR5, TLR6) was higher (fold change >1.5) in SAH neutrophils compared to healthy neutrophils (Fig. 3B) . In addition, genes associated with ER stress (GRP78, PERK, IRE1a, CHOP) and autophagy (ATG12, ATG7, ATG5, LC3b, LC3a) showed increased expression (fold change >1.5) in SAH neutrophils compared to healthy neutrophils (Fig. 3C) . Except for NGAL, IL11, TLR1, TLR5, and TLR6 none of the abovementioned genes documented significantly increased expression in AC neutrophils (Fig. 3) . The results establish the fact of neutrophil activation and their priming in SAH patients.
PURIFIED SAH ALBUMIN TRIGGERS GENES INVOLVED IN NEUTROPHIL ACTIVATION
As shown above, the albumin in SAH patients is modified and capable of causing neutrophil activation and oxidative burst. We further checked expression of the above-mentioned genes in SAH-albumin-treated healthy neutrophils against untreated healthy neutrophils. Expression analysis revealed that SAH-albumin treatment of healthy neutrophils increased the expression of genes associated with neutrophil activation (NGAL), production of ROS (CYBA, NCF2, FMO2, NOX1, NOX4, NOXA1, NOXO1), intracellular antioxidation (CCS, GSR, SOD1, SOD2, SOD3), proapoptosis (CASP1, CASP8, BAD, BAX, TNFa), and migration of leukocytes (SELE, ICAM1, ICAM2, VCAM1, OCLN) (fold change >1.5) (Fig.  4A) . Further, it was also documented that SAHalbumin-treated healthy neutrophils had significantly (P < 0.05) higher expression of proinflammatory cytokines (IL1b, IL7, IL8, IL10, IL11, IL15) and various  TLR genes (TLR1, TLR2, TLR4, TLR5, TLR6) (Fig. 4B ) (>1.5 fold change). Additionally, no alteration in the expression of genes associated with ER stress (GRP78, PERK, IRE1a, CHOP) and autophagy (ATG12, ATG7, ATG5, BECN1, LC3b, LC3a) was documented in healthy neutrophils after SAHalbumin treatment (Fig. 4C) . Also, incubation of healthy neutrophils with AC-albumin documented similar expression patterns of the above-mentioned genes, but fold changes were significantly low compared to SAH-albumin treatment (P < 0.05) (Fig. 4) . Interestingly, it was documented that treatment with Baxter albumin of healthy neutrophils does not trigger genes involved in neutrophil activation, while treatment with albumin purified from HC plasma triggered genes involved in neutrophil activation in a very mild manner (Supporting Table S7 ). The results indicate an increase in neutrophil activation and respiratory burst with an increase in disease severity with increased albumin modifications.
IN VITRO OXIDIZED ALBUMIN ACTIVATES NEUTROPHILS AND INDUCES RESPIRATORY BURST
The levels of activation markers (NGAL and MPO) in healthy neutrophil supernatants were significantly (P < 0.05) higher after in vitro oxidized albumin treatment (NGAL 29.09 ng/mL, MPO 53.34 ng/mL) compared to nonoxidized albumin treatment (NGAL 5.28 ng/mL, MPO 27 ng/mL) (Fig. 5A,B) , suggesting that oxidized albumin promotes activation and degranulation of neutrophils. Further, the DHR test documented a significant (P < 0.05) increase of intracellular ROS in neutrophils incubated with in vitro oxidized albumin (MFI 5 1,553) in comparison to nonoxidized albumin (MFI 5 440) (Fig. 5C ), indicating the ability of oxidized albumin to induce oxidative burst in neutrophils.
IN VITRO OXIDIZED ALBUMIN TRIGGERS GENES INVOLVED IN NEUTROPHIL ACTIVATION
RT-PCR-based expression analysis revealed that in vitro oxidized albumin treatment of healthy neutrophils caused increased expression (fold change >1.5, P < 0.05) of genes associated with neutrophil activation (NGAL), production of ROS (CYBA, NCF2, FMO2, NOX1, NOX4, NOXA1, NOXO), intracellular antioxidation (CCS, GSR, SOD1, SOD2, SOD3), proapoptosis (CASP1, CASP8, BAD, BAX, TNFa), and migration of leukocytes (SELE, ICAM1, ICAM2, VCAM1, OCLN) compared to nonoxidized albumin treatment (Fig. 5D) . Further, expression of proinflammatory cytokines (IL1b, IL7, IL8, IL10, IL11, IL15) and various TLR genes (TLR1, TLR2, TLR4, TLR5, TLR6) was found significantly (P < 0.05) increased in the in vitro oxidized albumintreated healthy neutrophils compared to nonoxidized albumin-treated healthy neutrophils (Fig. 5E) . Additionally, no significant change in gene expression was observed for genes associated with ER stress (GRP78, PERK, IRE1a, CHOP) and autophagy (ATG12, ATG7, ATG5, BECN1, LC3b, LC3a) (Fig. 5F ) in either comparison. In summation, the results confirm the capacity of oxidized albumin to promote neutrophil responses.
Discussion
This study reveals the association between systemic oxidative stress, albumin modifications (predominantly oxidation), and neutrophil activation in a cohort of SAH patients. In human blood plasma, the antioxidant property predominantly rests with proteins like albumin, although several other low-MW antioxidants are also present in the circulation. (31) The free thiol groups in the plasma generally act as the foremost scavengers for various oxidants. The free Cys34 residue of circulating albumin provides the biggest fraction of free thiol group in plasma. (32) Systemic oxidative stress is known to be increased in ALD patients and is associated with the accumulation of various oxidants, saccharides, and toxins in the circulation. (11) Our data show enhanced oxidation of thiols in the circulating albumin from SAH patients, much more than in AC patients and HCs.
Increased ROS and toxins have been shown in previous studies to produce spontaneous structural modifications in the circulating albumin molecule and oxidation of thiols in ALD patients. (17, 33) The oxidation of free thiol groups of albumin could be either reversible (mild) or irreversible (severe), depending upon the quality and quantity of the interacting oxidants. (34) Our data show a significant increase in the sulfinylated HSA (HNA2; Table 2 ), indicating irreversible oxidation of Cys34 and positively correlating with disease severity and oxidative stress. In addition, nonglycosylated HMA (native HSA, carrying a reduced Cys34), the only fraction of albumin with fully preserved structure, (19) was found to be depleted with increased severity of liver disease. We hypothesized that the determination of the oxidative state of serum albumin would offer not only valuable information about the redox state of the human body but also alterations in the conformation and function of albumin which may produce modifications in its biological properties. We therefore analyzed the plasma albumin by LC-MS to investigate the extent of oxidation of albumin in SAH patients. The oxidation of plasma albumin in these patients was more extensive and severe (Table 2) and may be one of the important pathological conditions responsible for systemic complications in SAH. (35, 36) The results of our study demonstrate that oxidative damage of circulating albumin in SAH destroys the homeostatic balance between plasma antioxidant and prooxidant properties, potentially generating a vicious circle of progressive systemic oxidative stress.
To test the hypothesis that the increased oxidative stress in plasma of SAH patients is because of oxidized albumin, we examined the effects of purified albumin from SAH patients on healthy neutrophils. We found that purified albumin from SAH patients (SAH-albumin) activates healthy neutrophils, leading to the degranulation and exocytosis of NGAL/MPO (Fig.  2B,C) . Moreover, several studies have shown that the consequence of neutrophil activation is respiratory burst, i.e., the release of ROS through neutrophil reduced nicotinamide adenine dinucleotide phosphate oxidase. (37, 38) We found that purified albumin from SAH patient plasma induced oxidative stress through a neutrophil respiratory burst (Fig. 2D) . In previous studies, it was demonstrated that excess AOPP-modified albumin was associated with a high level of respiratory burst in neutrophils, but albumin modification was performed in vitro by chemical reactions. (39) In our present study, albumin circulating in the plasma of SAH patients was found to have been modified in vivo, and incubation of purified albumin from these patients induced oxidative stress in healthy neutrophils. ROS from the oxidative burst may then attack neighboring macromolecules such as albumin. Further, activated neutrophils release MPO, which principally produces the reactive oxidants of halogenides (21) ; and these halogenated oxidants can also attack the surrounding albumin molecules. Thus, our study shows that modified (majorly oxidized) albumin in the circulation can act as a mediator of the selfpropagating oxidation cycle through activation of circulating neutrophils.
The in vivo activation status of neutrophils and their priming state were investigated in our SAH patients by gene expression profiling. An elevated state of activation as well as increased ROS production, intracellular antioxidation, leukocyte migration, proinflammatory cytokine production, and various TLRs were seen in circulatory neutrophils from SAH patients. Interestingly, stimulation of healthy circulatory neutrophils with SAH-albumin produced a similar gene expression profile, suggesting participation of oxidized SAH-albumin in neutrophil-mediated oxidative stress as well as neutrophilic infiltration or inflammation. This is in conformity with previous studies in SAH patients. (40, 41) Further, the enhanced expression of intracellular antioxidant genes in SAH neutrophils and in SAH-albumin-treated healthy neutrophils demonstrates the compensatory protective mechanism of cells against oxidative stress-mediated damage. Additionally, the enhanced transcript profile for apoptosis, ER stress, and autophagy in SAH neutrophils were not observed in SAH-albumin-treated healthy neutrophils, suggesting roles for other pathological mechanisms in SAH patients, which have been well documented in other studies. (8) Interestingly, our study shows that SAH-albumin treatment of healthy neutrophils caused up-regulation of the BAD, BAX, CASP8, and TNFa genes, indicating that SAH-albumin may induce mitochondrial dislocation in neutrophils, though this warrants further investigation. Thus, our study demonstrates that besides other known mechanisms, the modified circulatory albumin (majorly oxidized) serves as a substantial source for activation and priming of neutrophils in SAH patients and may contribute to the vascular complications (36) in these patients. Further, activation of healthy neutrophils by in vitro oxidized albumin (prepared by exposing commercial albumin to ROS generated through a Fenton reaction) in our study (Fig. 5) again demonstrates the capacity of oxidized albumin to stimulate ROS production and proinflammatory activation in neutrophils.
Our results clearly argue that in SAH patients, due to ongoing hepatic injury, systemic inflammation, and increased oxidative stress, plasma proteins, especially albumin, continuously get exposed to various reactive oxidants and toxins, resulting in extensive oxidative modifications, which act as potent oxidants for activation of immune cells such as neutrophils. Therefore, this modified circulating albumin perpetuates the cycle of oxidative stress, inflammation, and systemic complications in SAH patients.
